Who owns CYCLACEL PHARMACEUTICALS?
- CUSIP Number: 23254l603
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclacel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cyclacel Pharmaceuticals stock
Who bought or sold CYCLACEL PHARMACEUTICALS this quarter?
There are no current stakeholders of Cyclacel Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Cyclacel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Acadian Asset Management | Sep 2023 | 363k | $124k |
| Geode Capital Management | Sep 2023 | 86k | $30k |
| Northern Trust | Sep 2023 | 15k | $5.3k |
| BlackRock | Sep 2023 | 4.7k | $1.7k |
| Tower Research Capital | Sep 2023 | 3.6k | $1.3k |
| Morgan Stanley | Sep 2023 | 1.2k | $426.000000 |
| Qube Research & Technologies | Sep 2023 | 50.00 | $17.000000 |